About ADAA / FAQ / Press Room / Donate
CBT Augmentation of Paroxetine Treatment of Social Phobia
The purpose of this study is to compare the efficacy of two different treatment protocols for patients with social phobia (also known as social anxiety disorder). All patients will be treated with paroxetine for 12 weeks. After the first 12 weeks, study participants who have shown minimal response or better will be randomly assigned to either (1) remain on paroxetine for an additional 16 weeks or (2) receive individual cognitive-gehavioral therapy (CBT) plus paroxetine for an additional 16 weeks. All patients are followed up for an 24 weeks thereafter. All evaluations and treatments are provided at no charge to study participants.
Organization:
Temple University
Principal Investigator:
Richard G. Heimberg, PhD
Eligibility Criteria:
Men and women between the ages of 18 and 65 who have a primary diagnosis of generalized social phobia, as defined by DSM-IV. Patients cannot have had a previous adequate trial of either paroxetine or CBT for social phobia. Patients must not have clinically significant and/or unstable medical disease or mental disorder. Please contact the study coordinator for further details.
Contact:
215-204-1575 or phobia@temple.edu
Location:
Philadelphia, PA
State:
Pennsylvania
